Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Science 37

Science 37?uq=3Oe4kK1Z
2014 FOUNDED
PRIVATE STATUS
Series D LATEST DEAL TYPE
7 INVESTORS
Description

Developer of innovative clinical research technology intended to make clinical trials better for patients. The company's cloud-based patient-centric mobile research platform connects everyone safely and securely, resulting in site-less clinical trials, enabling healthcare institutions to make clinical research faster to accelerate biomedical discovery.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Application Software
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 12121 Bluff Creek Drive
  • Suite 100
  • Los Angeles, CA 90094
  • United States

+1 (984) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Science 37’s full profile, request a free trial.

Science 37 Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series D) 01-Jan-2018 000.00 Completed Profitable
3. Later Stage VC (Series C) 25-Apr-2017 0000 000.00 00000 Completed Startup
2. Early Stage VC (Series B) 18-Oct-2016 $31M $37.5M 00000 Completed Startup
1. Early Stage VC (Series A) 20-Oct-2015 $6.5M $6.5M 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Science 37 Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
Series A 6,746,233 $0.000100 $0.08 $0.96 $0.96 1x $0.96 19.29%
To view this company’s complete Cap Table, request access »

Science 37 Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Amgen Ventures Corporate Venture Capital Minority 000 0000 000000 0
Glynn Capital Venture Capital Minority 000 0000 000000 0
GV Corporate Venture Capital Minority 000 0000 000000 0
Redmile Group Hedge Fund Minority 000 0000 000000 0
Sanofi-Genzyme Bioventures Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Science 37 Executive Team (28)

Name Title Board
Seat
Contact
Info
Noah Craft Ph.D Co-Founder, Chief Executive Officer, Advisor & Board Member
Audrey Cavenecia Chief Marketing Officer, Media and Marketing
Haroon Ahmed Shakoor Corporate Controller
Christopher Ceppi Chief Product Officer
Horacio Herrera-Fajer Strategic Impact Manager

4 Former Executives

You’re viewing 5 of 28 executives. Get the full list »

Science 37 Board Members (8)

Name Representing Role Since Contact
Info
Aaron Nelson Ph.D dRx Capital Board Observer 000 0000
Adam Goulburn Ph.D Lux Capital Board Member 000 0000
Belinda Tan Ph.D Science 37 Co-Founder, Chief Medical Officer & Board Member 000 0000
Itai Danovitch MD Science 37 Board Member 000 0000
Lucian Iancovici MD dRx Capital Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »